Medically relevant compounds can often be found in nature. To make them suitable for drugs, they need to be isolated from their natural sources. If sufficient quantities of the agent cannot be isolated in that manner,...
An increasing number of bacteria are developing resistance to commonly used antibiotics, making it imperative to advance research into new antibiotics for clinical and medical use. Olga Kalinina, the new endowed...
The treatment of hepatitis C has been based on specific effective antiviral medications for a number of years. Since future development of resistance cannot be ruled out, alternative treatment options are being...
Dendritic cells act as the guardians of our immune system. They are lurking for foreign invaders, swallow them, break them into pieces and present the fragments on the cell surface. When the dendritic cells and their...
On 20 February 2019, the Helmholtz Centre for Infection Research (HZI) and Evotec AG announced their cooperation, scheduled for three years initially. They aim to develop new antibiotics that overcome resistant...
For the characterization of new bioactive metabolites from tropical Basidiomycetes, a division of fungi, Dr Clara Chepkirui of the Helmholtz Centre for Infection Research (HZI) in Brunswick was awarded this year’s...
Prof Markus Cornberg, a medical doctor by training, is the new Clinical Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Cornberg will also become director of the Centre for Individualised...
He was one of the most versatile German researchers and a popular representative of science. Manfred Eigen, winner of the Nobel Prize in Chemistry and one of the founders of the Gesellschaft für Biotechnologische...
Many common antibiotics are increasingly losing their effectiveness against multi-resistant pathogens, which are becoming ever more prevalent. Bacteria use natural means to acquire mechanisms that protect them from...
